Literature DB >> 20326936

Coxsackie B5 Virus as a Cause of Neonatal Encephalitis and Myocarditis.

D M McLean, W L Donohue, C E Snelling, J C Wyllie.   

Abstract

Entities:  

Year:  1961        PMID： 20326936      PMCID： PMC1848538     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Coxsackie B5 virus in association with pericarditis and pleurodynia.

Authors:  D M McLEAN; S J WALKER; H W BAIN
Journal:  Can Med Assoc J       Date:  1958-11-15       Impact factor: 8.262

2.  Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent.

Authors:  S KIBRICK; K BENIRSCHKE
Journal:  Pediatrics       Date:  1958-11       Impact factor: 7.124

3.  Encephalomyelitis, myocarditis and adrenal cortical necrosis in Coxasackie B3 virus infection. Distribution of the central nervous system lesions.

Authors:  J MOOSSY; J C GEER
Journal:  Arch Pathol       Date:  1960-11

4.  Fatal coxsackie group B virus infection in the newborn; report of a case with necropsy findings and brief review of the literature.

Authors:  M L SUSSMAN; L STRAUSS; H L HODES
Journal:  AMA J Dis Child       Date:  1959-04

5.  Acute aseptic myocarditis and meningoencephalitis in the newborn child infected with coxsackle virus group B, type 3.

Authors:  K BENIRSCHKE; S KIBRICK
Journal:  N Engl J Med       Date:  1956-11-08       Impact factor: 91.245

6.  Serious Coxsackie infection in infants and children; myocarditis, meningoencephalitis, and hepatitis.

Authors:  D M HOSIER; W A NEWTON
Journal:  AMA J Dis Child       Date:  1958-09
  6 in total
  9 in total

1.  NEW VIRAL EXANTHEMS.

Authors:  D F OSBORNE
Journal:  Can Med Assoc J       Date:  1964-02-15       Impact factor: 8.262

2.  [Coxsackie virus infections].

Authors:  J COUVREUR
Journal:  Arch Gesamte Virusforsch       Date:  1963

Review 3.  Coxsackie B antigen in the central nervous system of a patient with fatal acute encephalitis: immunohistochemical studies of formalin-fixed paraffin-embedded tissue.

Authors:  S Kamei; S M Hersch; T Kurata; Y Takei
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Coxsackie group B fatal neonatal myocarditis associated with cardiomegaly.

Authors:  R C Jennings
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

5.  Myocarditis due to coxsackie group A type 9 virus. Clinical and experimental study.

Authors:  G Christodoulopoulou; M Havredaki
Journal:  Arch Gesamte Virusforsch       Date:  1968

6.  Viral infections of Toronto children during 1965. I. Enteroviral disease.

Authors:  D M McLean; M A Coleman; R P Larke; G A McNaughton
Journal:  Can Med Assoc J       Date:  1966-04-16       Impact factor: 8.262

7.  Two cases of coxsackie B2 infection in neonates: clinical, virological, and epidemiological aspects.

Authors:  W Schürmann; A Statz; T Mertens; E Gladtke; H J Eggers
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

8.  ENTEROVIRAL SYNDROMES IN TORONTO, 1964.

Authors:  D M MCLEAN; R P LARKE; G A MCNAUGHTON; P SMITH
Journal:  Can Med Assoc J       Date:  1965-03-27       Impact factor: 8.262

9.  Neonatal coxsackie B virus infection-a treatable disease?

Authors:  Penelope A Bryant; David Tingay; Peter A Dargaville; Mike Starr; Nigel Curtis
Journal:  Eur J Pediatr       Date:  2004-02-18       Impact factor: 3.183
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.